CLEVELAND -- The pace at Cleveland's Global Center for Health Innovation is quickening.
The recent announcement that BioEnterprise and Accenture have formed a Cleveland-based working group, at the Global Center, to fight opioid addiction represents a noteworthy collaborative effort to address a national scourge. The working group was created after the second of the Global Center's Executive Briefing Series, which is attracting thought leaders from across the country eager to take on some of society's greatest health care challenges.
Image: Aram Nerpouni is CEO of BioEnterprise.
